Congo vs Italy: HIV/AIDS deaths averted by antiretroviral therapy
Congo
4,099 deaths
in 2024
Italy
4,048 deaths
in 2024
Congo rank
43rd
Italy rank
45th
HIV/AIDS deaths averted by antiretroviral therapy over time
- Congo
- Italy
How they compare
Congo currently reports 4,099 deaths against 4,048 deaths in Italy, a difference of 51 deaths.
The two have swapped places 1 time across 35 shared years of data; in 1990 it was Italy ahead.
Congo ranks 43rd and Italy ranks 45th of 157 countries.
Italy has averaged higher in every one of the 4 decades both report.
Head to head by decade
| Decade | Congo | Italy | Difference | Ahead |
|---|---|---|---|---|
| 1990s | 0 deaths | 710.23 deaths | 710.23 deaths | Italy |
| 2000s | 655.59 deaths | 4,451 deaths | 3,796 deaths | Italy |
| 2010s | 2,300 deaths | 4,398 deaths | 2,099 deaths | Italy |
| 2020s | 3,230 deaths | 4,155 deaths | 925.22 deaths | Italy |
Averages of every year both report within each decade.
Frequently asked questions
- Which has higher hiv/aids deaths averted by antiretroviral therapy, Congo or Italy?
- Congo, at 4,099 deaths against 4,048 deaths in Italy as of 2024.
- What is the difference in hiv/aids deaths averted by antiretroviral therapy between Congo and Italy?
- 51 deaths, with Congo ahead.
- How many years of comparable data are there for Congo and Italy?
- 35 years are reported by both, from 1990 to 2024.
- How do Congo and Italy rank globally for hiv/aids deaths averted by antiretroviral therapy?
- Congo ranks 43rd and Italy ranks 45th of 157 countries.
- Where does this data come from?
- Joint United Nations Programme on HIV/AIDS (2026) – with minor processing by Our World in Data, published as HIV/AIDS deaths averted by antiretroviral therapy. Statizoid refreshes it automatically from the source and publishes the full history for both places.
Individual pages
About this data
Number of deaths prevented as a direct result of Antiretroviral Therapy (ART) among people living with HIV. It is calculated by comparing the observed mortality rates in individuals receiving ART to the estimated mortality rates in the absence of such treatment. This is the central estimate.